Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

What are the symptoms of emphysema? - Understanding the condition is the first step towards taking control of your lung ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

For the first time Australian researchers have identified how exposure to smoking may cause a deadly lung disease that claims ...

A serious health risk affecting your lungs and heart. Whether you're experiencing respiratory distress or seeking preventive ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

How many cases of HMPV has India reported? The answer is: more than 15. Meanwhile, China said, “...the increase of reports ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.